Antibodies to neural proteins in organophosphorus-induced delayed neuropathy (OPIDN) and its amelioration

Neurotoxicology and Teratology

Volumn 30, Issue 3, 2008, Pages 161-166

  El Fawal, Hassan A N ^a   McCain, Wilfred C ^b  

^a MERCY COLLEGE   (United States)

^b U S ARMY CENTER FOR HEALTH PROMOTION AND PREVENTIVE MEDICINE   (United States)

Author keywords

Antibodies; Biomarkers; Neurotoxicity; OPIDN; Verapamil

Indexed keywords

ANTIBODY; BIOLOGICAL MARKER; ESTERASE; GLIAL FIBRILLARY ACIDIC PROTEIN; IMMUNOGLOBULIN G; MYELIN BASIC PROTEIN; NEUROFILAMENT H PROTEIN; NEUROFILAMENT L PROTEIN; NEUROFILAMENT M PROTEIN; NEUROFILAMENT PROTEIN; ORGANOPHOSPHORUS COMPOUND; VERAPAMIL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY BLOOD LEVEL; ARTICLE; ASTROCYTE; BLOOD SAMPLING; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HEN; NERVE DEGENERATION; NEUROPATHOLOGY; NEUROPATHY; NEUROTOXICITY; NONHUMAN; OCCUPATIONAL EXPOSURE; PRIORITY JOURNAL; SCORING SYSTEM; SERUM; VEIN PUNCTURE;

ANIMALS; ANTIBODIES; ASTROCYTES; AUTOANTIBODIES; BENZYL ALCOHOLS; CALCIUM CHANNEL BLOCKERS; CHICKENS; ENZYME-LINKED IMMUNOSORBENT ASSAY; IMMUNOGLOBULIN G; MALE; MYELIN BASIC PROTEINS; NERVE TISSUE PROTEINS; NEUROTOXICITY SYNDROMES; ORGANOPHOSPHORUS COMPOUNDS; PERIPHERAL NERVOUS SYSTEM DISEASES; TRITOLYL PHOSPHATES; VERAPAMIL;

EID: 44149084650     PISSN: 08920362     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ntt.2008.01.005     Document Type: Article

References (56)

1. Abbas A.K., Lichtman A.H., and Pober J.S. B cell activation and antibody production. Cellular and Molecular Immunology. 4th ed. (2000), W. B. Saunders, NY 182-207
2. 10 particles and oxidative stress on macrophages and lung epithelial cells: modulating effects of calcium-signaling antagonists. Am. J. Physiol., Lung Cell Mol. Physiol. 292 (2007) L1444-L1451
3. Bouras C., Riederer B.M., Kovari E., Hof P.R., and Giannakopoulos P. Humoral immunity in brain aging and Alzheimer's disease. Brain Res. Rev. 48 (2005) 477-487
4. Carden M.J., Schlaepfer W.W., and Lee V.M. The structure, biochemical properties, and immunogenicity of neurofilament peripheral regions are determined by phosphorylation state. J. Biol. Chem. 260 (1985) 9805-9817
5. Choudhary S., Verma S.K., Raheja G., Kaur P., Joshi K., and Gill K.D. The L-type calcium channel blocker nimodipine mitigates cytoskeletal proteins phosphorylation in dichlorvos-induced delayed neurotoxicity in rats. Basic Clin. Pharmacol. Toxicol. 9 (2006) 447-455
6. Choudhary S., and Gill K.D. Protective effect of nimodipine on dichlorvos-induced delayed neurotoxicity in rat brain. Biochem. Pharmacol. 62 (2001) 1265-1272
7. Costa L. Biomarker research in neurotoxicology: the role of mechanistic studies to bridge the gap between the laboratory and epidemiological investigations. Environ. Health Perspect. 104 Supl 1 (1996) 55-67
8. Dahlstrom A., Wigander A., Lundmark K., Gottfries C.G., Carvey P.M., and McRae A. Investigations on auto-antibodies in Alzheimer's and Parkinson's diseases, using defined neuronal cultures. J. Neural Transm. 129 (1990) 195-206 (Suppl)
9. de Vos A.F., van Meurs M., Brok H.P., Boven L.A., Hintzen R.Q., van der Valk P., Ravid R., Rensing S., Boon L., 't Hart B.A., and Laman J.D. Transfer of central nervous system autoantigens and presentation in secondary lymphoid organs. J. Immunol. 169 (2002) 5415-5423
10. Dugas B., Vazquez A., Klein B., Delfraissy J.-F., Rammou M.-T., Gérard J.-P., and Galanaud P. Early events in human B cell activation: metabolic pathways vary according to the first signal used. Eur. J. Immunol. 16 (2005) 1609-1614
11. Ehrich M., Hancock S., Ward D., Holladay S., Pung T., Flory L., Hinckley J., and Jortner B.S. Neurologic and immunologic effects of exposure to corticosterone, chlorpyrifos, and multiple doses of tri-ortho-tolyl phosphate over a 28-day period in rats. J. Toxicol. Environ. Health, Part A 67 (2004) 431-457
12. Ehrich M., and Jortner B.S. Organophosphate-induced delayed neuropathy. Handbook of Neurotoxicology vol. 1 (2001), Humana Press, New York 17-27
13. El-Fawal H.A.N. Concepts of immunological markers of metal toxicity. In: Chang L. (Ed). Metal Toxicity (1996), CRC Press, Inc., Boca Raton, Florida 857-865
14. El-Fawal H.A.N., Jortner B.S., and Ehrich M. Effect of verapamil on organophosphorus-induced delayed neuropathy in hens. Toxicol. Appl. Pharmacol. 97 (1989) 500-511
15. El-Fawal H.A.N., Correll L., Gay L., and Ehrich M. Protease activity in brain, nerve, and muscle in hens given neuropathy inducing organophosphates and a calcium channel blocker. Toxicol. Appl. Pharmacol. 103 (1990) 133-142
16. El-Fawal H.A.N., Jortner B.S., and Ehrich M. Modification of phenyl saligenin phosphate-induced delayed effects by calcium channel blockers: in vivo and in vitro electrophysiological assessment. Neurotoxicology 11 (1990) 573-592
17. El-Fawal H.A.N., and Ehrich M.F. Calpain activity during organophosphate-induced delayed neuropathy (OPIDN): effects of a phenylalkylamine calcium channel blocker. Ann. N Y. Acad. Sci. 642 (1993) 325-329
18. El-Fawal H.A.N., Gong Z.L., Little A.R., and Evans H.L. Exposure to methyl mercury results in serum autoantibodies to neurotypic and gliotypic proteins. Neurotoxicology 17 (1996) 531-540
19. El-Fawal H.A.N., Waterman S.J., De Feo A., and Shamy M.Y. Neuroimmunotoxicology: humoral assessment of neurotoxicity and autoimmune mechanisms. Environ. Health Perspect. 107 Supl 5 (1999) 775-680
20. Frank R.A., Galasko D., Hampel H., Hardy J., de Leon M.J., Mehta P.D., Rogers J., Siemers E., and Trojanowski J.Q. Biological markers for therapeutic trials in Alzheimer's disease. Neurobiol. Aging 24 (2003) 521-536
21. Guizzetti M., Pathak S., Giordano G., and Costa L.G. Effect of organophosphorus insecticides and their metabolites on astroglial cell proliferation. Toxicology 215 (2005) 182-190
22. 2+/calmodulin-dependent protein kinase in the brain subcellular fractions of diisopropyl phosphorofluoridate (DFP)-treated hen. Neurochem. Res. 20 (2005) 1095-1105
23. Hargreaves A.J., Fowler M.J., Sachana M., Flaskos J., Bountouri M., Coutts I.C., Glynn P., Harris W., and Graham McLean W. Inhibition of neurite outgrowth in differentiating mouse N2a neuroblastoma cells by phenyl saligenin phosphate: effects on MAP kinase (ERK 1/2) activation, neurofilament heavy chain phosphorylation and neuropathy target esterase activity. Biochem. Pharmacol. 71 (2006) 1240-1247
24. Jensen K.F., Lapadula D.M., Anderson J.K., Haykal-Coates N., and Abou-Donia M.B. Anomalous phosphorylated neurofilament aggregations in central and peripheral axons of hens treated with tri-ortho-cresyl phosphate (TOCP). J. Neurosci. Res. 33 (1992) 455-460
25. Jortner B.S., Shell L., El-Fawal H.A.N., and Ehrich M. Myelinated nerve fiber regeneration following organophosphorus ester-induced delayed neuropathy. Neurotoxicology 10 (1989) 717-726
26. Kaufer D., Friedman A., and Soreq H. The vicious circle of stress and anticholinesterase responses. Neurosci. 5 (1999) 1-9
27. Kindt T.J., Goldsby R.A., and Osborne B.A. B-cell generation, activation and differentiation. Kuby Immunology. 6th edition (2007), W. H. Freeman, NY 271-301
28. Little A.R., Gong Z.L., Singh U., El-Fawal H.A.N., and Evans H.L. Decreases in brain glial fibrillary acidic protein (GFAP) are associated with increased serum corticosterone following inhalation exposure to toluene. Neurotoxicology 19 (1998) 739-747
29. Liu B., Gao H.M., and Hong J.S. Parkinson's disease and exposure to infectious agents and pesticides and the occurrence of brain injuries: role of neuroinflammation. Environ. Health Perspect. 111 (2003) 1065-1073
30. Lotti M. Organophosphorus compounds. In: Spenser P.S., and Schaumburg H.H. (Eds). Experimental and Clinical Neurotoxicology (2000), Oxford University Press, NY 897-925
31. McCain W.C., Flaherty D.M., Correll L., Jortner B.S., and Ehrich M. Catecholamine concentrations and contractile responses of isolated vessels from hens treated with cyclic phenyl saligenin phosphate or paraoxon in the presence or absence of verapamil. J. Toxicol. Environ. Health 48 (1996) 397-411
32. McConnell R., Delgado-Tellez E., Cuadra R., Torres E., Keifer M., Almendaraz J., Miranda J., El-Fawal H.A.N., Wolff M., Simpson D., and Lundberg I. Organophosphate neuropathy due to metamidophos: biochemical and neurophysiologic markers. Arch. Toxicol. 73 (1999) 296-300
33. Nieborj-Dobosz I., Dziewulska D., and Janik P. Auto-antibodies against proteins of spinal cord cells in cerebrospinal fluid of patients with amyotrophic lateral sclerosis (ALS). Folia Neuropathol. 44 (2006) 191-196
34. O'Callaghan J.P., Brinton R.E., and McEwen B.S. Glucocorticoids regulate the synthesis of glial fibrillary acidic protein in intact and adrenalectomized rats but do not affect its expression following brain injury. J. Neurochem. 57 (1991) 860-869
35. Orr C.F., Rowe D.B., Mizuno Y., Mori H., and Halliday G.M. A possible role for humoral immunity in the pathogenesis of Parkinson's disease. Brain 128 (2005) 2665-2674
36. Papachroni K.K., Ninkina N., Papapanagiotou A., Hadjigeorgiou G.M., Xiromerisiou G., Papadimitriou A., Kalofoutis A., and Buchman V. Autoantibodies to alpha-synuclein in inherited Parkinson's disease. J. Neurochem. (2006) 1471-4159 (OnlineEarly Articles)
37. Parran D.K., Magnin G., Li W., Jortner B.S., and Ehrich M. Chlorpyrifos alters functional integrity and structure of an in vitro BBB model: co-cultures of bovine endothelial cells and neonatal rat astrocytes. Neurotoxicology 26 (2005) 77-88
38. Pavlaković G., Kane M.D., Eyer C.L., Kanthasamy A., and Isom G.E. Activation of protein kinase C by trimethyltin: relevance to neurotoxicity. J. Neurochem. 65 (1995) 2338-2343
39. Poletaev A.B., Morozov S.G., Gnedenko B.B., Zlunikin V.M., and Korzhenevskey D.A. Serum anti-S100b, anti-GFAP and anti-NGF autoantibodies of IgG class in healthy persons and patients with mental and neurological disorders. Autoimmunity 32 (2000) 33-38
40. Poon H.F., Castegna A., Farr S.A., Thongboonkerd V., Lynn B.C., Banks W.A., Morley J.E., Klein J.B., and Butterfield D.A. Quantitative proteomics analysis of specific protein expression and oxidative modification in aged senescence-accelerated-prone 8 mice brain. Neuroscience 126 (2004) 915-926
41. Rowland L.P., and Shneider N.A. Amyotrophic lateral sclerosis. New Engl. J.Med. 344 (2001) 1688-1700
42. Scott D., Smith K.E., O'Brien B.J., and Angelides K.J. Characterization of mammalian neurofilament triplet proteins. Subunit stoichiometry and morphology of native and reconstituted filaments. J. Biol. Chem. 260 (1985) 10736-10747
43. Sinha C. Species variation in pesticide-induced blood-brain barrier dysfunction. Hum. Exp. Toxicol. 22 (2003) 647-652
44. Skowera A., Stewart E., Davis E.T., Cleare A.J., Unwin C., Hull L., Hossain G., Wessely S.C., and Peakman M. Antinuclear autoantibodies (ANA) in Gulf War-related illness and chronic fatigue syndrome (CFS) patients. Clin. Exp. Immunol. 129 (2002) 354-358
45. Skowera A., Hotopf M., Sawicka E., Varela-Calvino R., Unwin C., Nikolaou V., Hull L., Ismail I., David A.S., Wessely S.C., and Peakman M. Cellular immune activation in Gulf War veterans. J. Clin. Immunol. 24 (2004) 66-73
46. Song X., Pope C., Murthy R., Shaikh J., Lal B., and Bressler J.P. Interactive effects of paraoxon and pyridostigmine on blood-brain barrier integrity and cholinergic toxicity. Toxicol. Sci. 78 (2004) 241-247
47. Soussan L., Tchernakov K., Bachar-Lavi O., Yuvan T., Wertman E., and Michaelson D.M. Antibodies to different isoforms of the heavy neurofilament protein (NF-H) in normal aging and Alzheimer's disease. Mol. Neurobiol. 9 (1994) 83-91
48. Sprague G.L., Sandvik L.L., Bickford A.A., and Castles T.R. Evaluation of a sensitive grading system for assessing acute and subchronic delayed neurotoxicity in hens. Life Sci. 27 (1980) 2523-2528
49. Surendran G., and El-Fawal H.A.N. Neuroimmune responses to toxic agents: comparison of organometal electrophiles using detection of antibodies to neural cytoskeleton and myelin as biomarkers. J. Pharmacol. Toxicol. 3 (2008) 173-189
50. Swash M., and Ingram D.A. Adverse effect of verapamil in myasthenia gravis. Muscle Nerve 15 (1992) 396-398
51. Targoni O.S., Baus J., Hofstetter H.H., Hesse M.D., Karulin A.Y., Boehm B.O., Forsthuber T.G., and Lehmann P.V. Frequencies of neuroantigen-specific T cells in the central nervous system versus the immune periphery during the course of experimental allergic encephalomyelitis. J. Immunol. 166 (2001) 4757-4764
52. Terryberry J.W., Thor G., and Peter J.B. Autoantibodies in neurodegenerative diseases: antigen-specific frequencies and intrathecal analysis. Neurobiol. Aging 19 (1998) 205-216
53. Thrasher J.D., Heuser G., and Broughton A. Immunological abnormalities in humans chronically exposed to chlorpyrifos. Arch. Environ. Health 57 (2002) 181-187
54. Vojdani A., and Thrasher J.D. Cellular and humoral immune abnormalities in Gulf War veterans. Environ. Health Perspect. 112 (2004) 840-846
55. 45Ca uptake by brain synaptosomes in hens. Pestic. Biochem. Physiol. 77 (2003) 18-23
56. Wu Y.-J., Ming L., Li Y.-X., Li W., Dai J.-Y., and Leng X.-F. Verapamil abolished the enhancement of protein phosphorylation of brainstem mitochondria and synaptosomes from the hens dosed with tri-o-cresyl phosphate. Environ. Toxicol. Pharmacol. 24 (2007) 67-71